Interim data from phase 2 KYSA-6 study, using KYV-101 for the treatment of patients with Myasthenia Gravis, expected 2nd half ...

US FDA approves Novartis’ oral Fabhalta for treatment of adults with C3 glomerulopathy: Basel Saturday, March 22, 2025, 09:00 Hrs [IST] Novartis announced that oral Fabhalta (ip ...

Lorundrostat demonstrated strong efficacy and safety in the pivotal Phase 3 Launch-HTN and Phase 2 Advance-HTN trials. These ...

MacroGenics (NASDAQ: MGNX) Q4 2024 Earnings Call Mar 20, 2025, 4:30 p.m. ET ...

In a nutshell Workplace coffee machines contain higher levels of cholesterol-raising compounds (diterpenes) than ...

The 442 had legendary engines under the hood, including the 7.5-liter Rocket 455 V8 that delivered up to 400 hp and 500 lb-ft of torque. However, the 70s oil crisis and stricter emissions regulations ...

After surgeries, setbacks and a drop in the rankings, Emma Raducanu found something familiar -- and fulfilling -- in her win ...

Comprising three main variants and built from 1948 through 1954, the model combines sumptuous bodywork with impressive brawn.

Godrej Properties Ltd has purchased ~10 acres of land in Yelahanka, Bengaluru to develop ~1.5 million square feet of saleable ...

Finding the best CBD gummies for pain and inflammation is made easy with this comprehensive review of leading brands.

EAST HANOVER, NJ, USA I March 20, 2025 I Novartis today announced that oral Fabhalta® (iptacopan) has received U.S. Food and Drug Administration (FDA) ...

Six-time Miami champion Novak Djokovic, who is tied with Andre Agassi for most titles at the event, is back for the first time in six years and got off to a good start with a 6-0, 7-6 (7-1) second ...